Successive delivery of drugs for drug programs (3 packages)
Original notice title
Sukcesywna dostawa leków do programów lekowych – 3 pakiety
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
55 / 100
Risk factors
Missing procurement documents; tender conditions may include additional qualification criteria or contract terms not vi...
Strict exclusion grounds related to sanctions, cybersecurity, and capital group could disqualify if not properly addres...
Submission deadline in 5 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 3 lots
- Successive delivery of medicines for drug programs
- Three separate lots: immunoglobulin and two natalizumab products
Show full summary
This is an open tender by Instytut Psychiatrii i Neurologii in Warsaw, Poland, for the successive supply of pharmaceutical products across three lots. The tender is 100% price-based, with electronic submission required in Polish. No estimated value is provided, and no procurement documents were analyzed. The contract duration is 12 months.
Risks
Missing procurement documents; tender conditions may include additional qualification criteria or contract terms not vi...
Strict exclusion grounds related to sanctions, cybersecurity, and capital group could disqualify if not properly addres...
Submission deadline in 5 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Tender guarantee not specified
Administrative
- Electronic submission required
- Submission in Polish language only
Requirements may be incomplete.
Award Criteria
Lot 1
Lot 2
Lot 3
Buyer
Name
Instytut Psychiatrii i Neurologii
Location
Warszawa, POL
Buyer profile
Identifier
5250009387
Lots (3)
LOT-0001
Pakiet nr 1
Supply of Immunoglobulin Humannum solution for subcutaneous administration 200 mg/ml.
Location
Category
Deadline
Award details
Show original TED data
Original TED description
Immunoglobulin Humannum roztwór do podawania podskórnego 200 mg/ml
LOT-0002
Pakiet nr 2
Supply of Natalizumab 20 mg/ml vial 15.
Location
Category
Deadline
LOT-0003
Pakiet nr 3
Supply of Natalizumab 150 mg/ml 2 ampoules of 1 ml.
Location
Category
Deadline
Procurement Details
- Publication date
- 28 May 2026
- Notice type
- Contract notice — standard
- Languages
- Polish
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 369459-2026
- Source notice ID
- bb01aa77-e43f-4a41-ad15-8dcbed2acbb4
Documents (1)
Similar tenders
Poland – Various medicinal products – ZP.220.99.26 Dostawa różnych produktów leczniczych, żywności medycznej oraz preparatów do żywienia pacjentów na potrzeby
Poland – Antineoplastic agents – Dostawa produktów leczniczych i wyrobów medycznych do Wojskowego Instytutu Medycznego – PIB
Poland – Antithrombotic agents – Dostawa produktów leczniczych do leczenia zaburzeń w funkcjonowaniu przewodu pokarmowego, środków antybakteryjnych do użytku ogólnoustrojowego (...) w podziale na 21 części.
Slovakia – Medicinal products for the alimentary tract and metabolism – Liečivá pre výživovú sústavu a látkovú premenu
Belgium – Immunoglobulins – Immunoglobulinen voor intraveneuze toediening (IVIG)
Belgium – Plasma extracts – Raamovereenkomst voor de aankoop van IV Immunoglobulinen en Protrombine complex concentraat
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
55 / 100
Risk factors
Missing procurement documents; tender conditions may include additional qualification criteria or contract terms not vi...
Strict exclusion grounds related to sanctions, cybersecurity, and capital group could disqualify if not properly addres...
Submission deadline in 5 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications